SCINAI IMMUNOTHERAPEUTICS LTD. Cash and Cash Equivalents
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Cash and Cash Equivalents of $1.66 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-04-01
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $1.66M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $989.00K.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $1.96M.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $3.08M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $1.66M 20-F · filed 2026-04-01 |
| 2025-06-30 | $989.00K 6-K · filed 2025-09-02 |
| 2024-12-31 | $1.96M 20-F · filed 2026-04-01 |
| 2024-06-30 | $3.08M 6-K · filed 2025-09-02 |
| 2023-12-31 | $4.87M 20-F · filed 2026-04-01 |
| 2023-06-30 | $7.51M 6-K · filed 2024-09-09 |
| 2023-03-31 | $10.80M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.07M 20-F · filed 2025-05-07 |
| 2022-06-30 | $11.29M 6-K/A · filed 2023-08-18 |
| 2022-03-31 | $15.39M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $17.37M 20-F · filed 2024-05-15 |